About 7 million children in the United States have Asthma.

With the increasing rates of pediatric Asthma, parents are seeking for alternative treatments to β2 receptor agonists and anti-inflammatory drugs (inhaled corticosteroids or leukotriene receptor antagonist), traditionally prescribed for children at risk with Asthma exacerbation.

A study published in 2016 evaluated the effect of Halotherapy (salt therapy) on BHR, FeNO for a better life quality in children with Asthma. The study examined children from 5 to 13 years old, clinically diagnosed with mild Asthma, which were not treated with anti-inflammatory therapy.

The study consisted of two groups treated in salt room – one (treatment group) with and the other (control group) without halogenerator.

The results had shown a statistically significant improvement on BHR and quality-of-life in the treatment group, which was not demonstrated in the control group.

View Fullscreen